Skip to Main Content

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.

Buongiorno! We’re now officially in this year’s home stretch. For me, that means I am flying home to Italy (with Tuna — please send any and all tips for long flights with spicy little dogs) at the end of this week. Meanwhile, don’t miss Allison DeAngelis’s fascinating profile on Reed Jobs and his investment in oncology.

advertisement

Reed Jobs charts his own course in biotech

For Steve Jobs’ son, Reed, his father’s cancer wasn’t just cause for heartbreak and grief. It was also what led him down the path that culminated this past August with the founding of Yosemite, an investment firm focused exclusively on oncology research, with $200 million in financing and plans to raise $200 million more.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.